Pharmaceutical Antitrust Enforcement in the Trump Administration
Forecast Based on Past Administrations and Current Trends
Overcoming Antimicrobial Drug Resistance
If Not Tackled Now, by 2050, the Death Toll Could Be One Person Every Three Seconds
Advances in PCR Technology and Its Applications in Healthcare Research
Breaking Through Barriers between Benchtop and Bedside
Cannibalism: A Biological and Evolutionary Perspective
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Synthetic Bio Not Yet Ready for the Market
Lab-Designed Calls and Pathways Take Genetic and Metabolic Engineering to Next Level
- In May of this year, the J. Craig Venter Institute (JCVI) announced it had created the first fully synthetic, self-replicating bacterial cell ( Mycoplasma nycoides JCVI-syn1.0). While this proof-of-concept demonstration of an “artificial life form” might raise justifiable fears about the dangers of unregulated or nefarious synthetic biology efforts, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.